G01N 33/56988
Hiv or htlv
Official title: {HIV or HTLV}
G01N33/56988 (Hiv or htlv) appears on 784 US grants and 688 published applications in this corpus.
Search patents in G01N- Granted patents
- 784
- Published applications
- 688
- Assignees
- 457
- Inventors
- 1,630
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 5 | 0 |
| 1988 | 5 | 0 |
| 1989 | 17 | 0 |
| 1990 | 13 | 0 |
| 1991 | 16 | 0 |
| 1992 | 17 | 0 |
| 1993 | 14 | 0 |
| 1994 | 19 | 0 |
| 1995 | 23 | 0 |
| 1996 | 30 | 0 |
| 1997 | 46 | 0 |
| 1998 | 69 | 0 |
| 1999 | 38 | 0 |
| 2000 | 33 | 0 |
| 2001 | 43 | 8 |
| 2002 | 28 | 39 |
| 2003 | 29 | 48 |
| 2004 | 17 | 35 |
| 2005 | 11 | 42 |
| 2006 | 16 | 31 |
| 2007 | 17 | 23 |
| 2008 | 11 | 26 |
| 2009 | 13 | 31 |
| 2010 | 15 | 35 |
| 2011 | 11 | 29 |
| 2012 | 12 | 17 |
| 2013 | 17 | 28 |
| 2014 | 15 | 43 |
| 2015 | 14 | 48 |
| 2016 | 21 | 24 |
| 2017 | 27 | 29 |
| 2018 | 22 | 19 |
| 2019 | 27 | 20 |
| 2020 | 16 | 20 |
| 2021 | 16 | 26 |
| 2022 | 8 | 21 |
| 2023 | 9 | 9 |
| 2024 | 8 | 16 |
| 2025 | 6 | 14 |
| 2026 | 8 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-human immunodeficiency virus-1 antibodies and methods for uses thereof29 Sep 2026US 12,747,285 B2Grifols Diagnostic Solutions Inc.
- Method for diagnosing human T-cell leukemia virus type 1 (HTLV-1)-related disease16 Jun 2026US 12,656,345 B2NEC Corporation
- Antiviral immunotherapy by membrane receptor ligation5 May 2026US 12,617,842 B2Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
- Human broadly neutralizing antibodies against the membrane-proximal external region of HIV Env for vaccine design and intervention5 May 2026US 12,617,843 B2The Scripps Research Institute
- Methods of identifying HIV patients sensitive to therapy with gp120 CD4 binding site-directed antibodies24 Feb 2026US 12,559,546 B2Gilead Sciences, Inc.
- Tcr-mimic bispecific antibodies for hiv-11 Oct 2026US 2026/0297193 A1The Johns Hopkins University
- Assays and reagents for the detection of soluble gp12027 Aug 2026US 2026/0251654 A1
- Anti-hiv antibodies30 Jul 2026US 2026/0217801 A1International AIDS Vaccine Initiative
- Conformationally Specific Viral Immunogens11 Jun 2026US 2026/0158104 A1Calder Biosciences Inc.
- Antibody against human immunodeficiency virus type 1 p24 and type 2 p26 and uses thereof30 Apr 2026US 2026/0118359 A1Hytest Ltd.
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Zinc finger protein derivatives and methods therefor323US 6,140,466 AThe Scripps Research Institute · 2000
- Zinc finger protein derivatives and methods therefor315US 6,242,568 B1The Scripps Research Institute · 2001